FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mary Rusckowski

Research Profile

Living Beings

Concepts & Ideas

Tissue Distribution

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Yuzhen Wang; Ling Chen; Dengfeng Cheng; Shuping Dou; Donald J Hnatowich; Guozheng Liu; Xinrong Liu; Yuxia Liu; Mary Rusckowski
Detection of Aspergillus fumigatus pulmonary fungal infections in mice with (99m)Tc-labeled MORF oligomers targeting ribosomal RNA.
Xinrong Liu; Yuxia Liu; Kayoko Nakamura; Cong Peng; Mary Rusckowski; Nan Xiao; Ling Chen; Dengfeng Cheng; Donald J Hnatowich
Her2/neu small interfering RNA delivered in culture by a streptavidin nanoparticle.
Xinrong Liu; Koon Y Pak; Mary Rusckowski; Yuzhen Wang; Ali Akalin; Dengfeng Cheng; Brian D Gray; Donald J Hnatowich
Radiolabeled Zn-DPA as a potential infection imaging agent.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mary Rusckowski (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Yuzhen Wang; Ling Chen; Dengfeng Cheng; Shuping Dou; Donald J Hnatowich; Guozheng Liu; Xinrong Liu; Yuxia Liu; Mary Rusckowski
Detection of Aspergillus fumigatus pulmonary fungal infections in mice with (99m)Tc-labeled MORF oligomers targeting ribosomal RNA.
Nuclear medicine and biology 2013;40(1):89-96.
2012: Xinrong Liu; Yuxia Liu; Kayoko Nakamura; Cong Peng; Mary Rusckowski; Nan Xiao; Ling Chen; Dengfeng Cheng; Donald J Hnatowich
Her2/neu small interfering RNA delivered in culture by a streptavidin nanoparticle.
Current drug delivery 2012;9(4):431-6.
2012: Xinrong Liu; Koon Y Pak; Mary Rusckowski; Yuzhen Wang; Ali Akalin; Dengfeng Cheng; Brian D Gray; Donald J Hnatowich
Radiolabeled Zn-DPA as a potential infection imaging agent.
Nuclear medicine and biology 2012;39(5):709-14.
2012: Guozheng Liu; Mary Rusckowski; Leonard D Shultz; Philip R Streeter; Ali Akalin; Shuping Dou; Dale L Greiner
Pretargeting vs. direct targeting of human betalox5 islet cells subcutaneously implanted in mice using an anti-human islet cell antibody.
Nuclear medicine and biology 2012;39(5):645-51.
2012: Hikaru Sugimoto; Gangadhar Taduri; Björn Tampe; Desiree Tampe; Michael Zeisberg; Wibke Bechtel; Philippe Bey; Dattatreyamurty Bosukonda; William Carlson; Keizo Kanasaki; Peter Keck; Valerie S LeBleu; Hirokazu Okada; Mary Rusckowski; Raghu Kalluri
Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis.
Nature medicine 2012;18(3):396-404.
2011: Ling Chen; Dengfeng Cheng; Shuping Dou; Donald J Hnatowich; Guozheng Liu; Xinrong Liu; Yi Wang; Mary Rusckowski
Comparing two TAG-72 binding peptides previously identified by phage display as potential imaging agents.
Nuclear medicine communications 2011;32(10):920-4.
2011: Dengfeng Cheng; Shuping Dou; Ling Chen; Minmin Liang; Guozheng Liu; Xinrong Liu; Yuxia Liu; P Hendrik Pretorius; Mary Rusckowski; Nan Xiao; Donald J Hnatowich
Improving the quantitation accuracy in noninvasive small animal single photon emission computed tomography imaging.
Nuclear medicine and biology 2011;38(6):843-8.
2011: Guozheng Liu; Shuping Dou; Dengfeng Cheng; Jean Leif; Mary Rusckowski; Philip R Streeter; Leonard D Shultz; Donald J Hnatowich; Dale L Greiner
Human islet cell MORF/cMORF pretargeting in a xenogeneic murine transplant model.
Molecular pharmaceutics 2011;8(3):767-73.
2011: Jack Hoppin; Kelly Davis Orcutt; Jacob Y Hesterman; Matthew D Silva; Dengfeng Cheng; Christian Lackas; Mary Rusckowski
Assessing antibody pharmacokinetics in mice with in vivo imaging.
The Journal of pharmacology and experimental therapeutics 2011;337(2):350-8.
2011: Minmin Liang; Xinrong Liu; Guozheng Liu; Shuping Dou; Dengfeng Cheng; Yuxia Liu; Mary Rusckowski; Donald J Hnatowich
Reducing the background fluorescence in mice receiving fluorophore/inhibitor DNA duplexes.
Molecular pharmaceutics 2011;8(1):126-32.
2011: Guozheng Liu; Shuping Dou; Yuxia Liu; Minmin Liang; Ling Chen; Dengfeng Cheng; Dale Greiner; Mary Rusckowski; Donald J Hnatowich
Unexpected side products in the conjugation of an amine-derivatized morpholino oligomer with p-isothiocyanate benzyl DTPA and their removal.
Nuclear medicine and biology 2011;38(2):159-63.
2011: Nan Xiao; Dengfeng Cheng; Yi Wang; Ling Chen; Xinrong Liu; Shuping Dou; Guozheng Liu; Minmin Liang; Donald J Hnatowich; Mary Rusckowski
Identification of a high affinity TAG-72 binding peptide by phage display selection.
Cancer biology & therapy 2011;11(1):22-31.
2010: Guozheng Liu; Shuping Dou; Xiangji Chen; Ling Chen; Xinrong Liu; Mary Rusckowski; Donald J Hnatowich
Adding a clearing agent to pretargeting does not lower the tumor accumulation of the effector as predicted.
Cancer biotherapy & radiopharmaceuticals 2010;25(6):757-62.
2010: Guozheng Liu; Shuping Dou; Stephen Baker; Ali Akalin; Dengfeng Cheng; Ling Chen; Mary Rusckowski; Donald J Hnatowich
A preclinical 188Re tumor therapeutic investigation using MORF/cMORF pretargeting and an antiTAG-72 antibody CC49.
Cancer biology & therapy 2010;10(8):767-74.
2010: Guozheng Liu; Shuping Dou; Mary Rusckowski; Dale Greiner; Donald J Hnatowich
Preparation of (111)In-DTPA morpholino oligomer for low abdominal accumulation.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2010;68(9):1709-14.
2010: Dengfeng Cheng; Yi Wang; Xinrong Liu; P Hendrik Pretorius; Minmin Liang; Mary Rusckowski; Donald J Hnatowich
Comparison of 18F PET and 99mTc SPECT imaging in phantoms and in tumored mice.
Bioconjugate chemistry 2010;21(8):1565-70.
2010: Minmin Liang; Xinrong Liu; Dengfeng Cheng; Guozheng Liu; Shuping Dou; Yi Wang; Mary Rusckowski; Donald J Hnatowich
Multimodality nuclear and fluorescence tumor imaging in mice using a streptavidin nanoparticle.
Bioconjugate chemistry 2010;21(7):1385-8.
2010: Guozheng Liu; Shuping Dou; P Hendrik Pretorius; Xinrong Liu; L Chen; Mary Rusckowski; Donald J Hnatowich
Tumor pretargeting in mice using MORF conjugated CC49 antibody and radiolabeled complimentary cMORF effector.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2010;54(3):333-40.
2010: Xinrong Liu; Kayoko Nakamura; Yi Wang; Dengfeng Cheng; Minmin Liang; Nan Xiao; Ling Chen; Mary Rusckowski; Donald J Hnatowich
Auger-mediated cytotoxicity of cancer cells in culture by an 125I-antisense oligomer delivered as a three-component streptavidin nanoparticle.
Journal of biomedical nanotechnology 2010;6(2):153-7.
2009: Yi Wang; Xinrong Liu; Ling Chen; Dengfeng Cheng; Mary Rusckowski; Donald J Hnatowich
Tumor delivery of antisense oligomer using trastuzumab within a streptavidin nanoparticle.
European journal of nuclear medicine and molecular imaging 2009;36(12):1977-86.
2009: Guozheng Liu; Shuping Dou; Minmin Liang; Xiangji Chen; Mary Rusckowski; Donald J Hnatowich
The ratio of maximum percent tumour accumulations of the pretargeting agent and the radiolabelled effector is independent of tumour size.
European journal of cancer (Oxford, England : 1990) 2009;45(17):3098-103.
2009: Minmin Liang; Xinrong Liu; Kayoko Nakamura; Xiangji Chen; Dengfeng Cheng; Guozheng Liu; Shuping Dou; Yi Wang; Mary Rusckowski; Donald J Hnatowich
A convenient thiazole orange fluorescence assay for the evaluation of DNA duplex hybridization stability.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2009;11(6):439-45.
2009: Yi Wang; Xinrong Liu; Kayoko Nakamura; Ling Chen; Mary Rusckowski; Donald J Hnatowich
In vivo delivery of antisense MORF oligomer by MORF/carrier streptavidin nanoparticles.
Cancer biotherapy & radiopharmaceuticals 2009;24(5):573-8.
2009: Guozheng Liu; Dengfeng Cheng; Shuping Dou; Xiangji Chen; Minmin Liang; P Hendrik Pretorius; Mary Rusckowski; Donald J Hnatowich
Replacing 99mTc with 111In improves MORF/cMORF pretargeting by reducing intestinal accumulation.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2009;11(5):303-7.
2009: Minmin Liang; Xinrong Liu; Dengfeng Cheng; Kayoko Nakamura; Yi Wang; Shuping Dou; Guozheng Liu; Mary Rusckowski; Donald J Hnatowich
Optical antisense tumor targeting in vivo with an improved fluorescent DNA duplex probe.
Bioconjugate chemistry 2009;20(6):1223-7.
2009: Xinrong Liu; Yi Wang; Kayoko Nakamura; Sumi Kawauchi; Ali Akalin; Dengfeng Cheng; Ling Chen; Mary Rusckowski; Donald J Hnatowich
Auger radiation-induced, antisense-mediated cytotoxicity of tumor cells using a 3-component streptavidin-delivery nanoparticle with 111In.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(4):582-90.
2008: Ling Chen; Yi Wang; Xinrong Liu; Shuping Dou; Guozheng Liu; Donald J Hnatowich; Mary Rusckowski
A new TAG-72 cancer marker peptide identified by phage display.
Cancer letters 2008;272(1):122-32.
2008: Xiangji Chen; Shuping Dou; Guozheng Liu; Xinrong Liu; Yi Wang; Ling Chen; Mary Rusckowski; Donald J Hnatowich
Synthesis and in vitro characterization of a dendrimer-MORF conjugate for amplification pretargeting.
Bioconjugate chemistry 2008;19(8):1518-25.
2008: Guozheng Liu; Shuping Dou; Mary Rusckowski; Donald J Hnatowich
An experimental and theoretical evaluation of the influence of pretargeting antibody on the tumor accumulation of effector.
Molecular cancer therapeutics 2008;7(5):1025-32.
2008: Mary Rusckowski; Suresh Gupta; Guozheng Liu; Shuping Dou; Donald J Hnatowich
Investigation of four (99m)Tc-labeled bacteriophages for infection-specific imaging.
Nuclear medicine and biology 2008;35(4):433-40.
2008: Lauren G Kleine; Mauricio Solano; Mary Rusckowski; Kathleen E Hunt; Karen L Johnson; Carl A Kirker-Head
Evaluation of technetium Tc 99m-labeled biotin for scintigraphic detection of soft tissue inflammation in horses.
American journal of veterinary research 2008;69(5):639-46.
2008: Guozheng Liu; Shuping Dou; P Hendrik Pretorius; Xinrong Liu; Mary Rusckowski; Donald J Hnatowich
Pretargeting CWR22 prostate tumor in mice with MORF-B72.3 antibody and radiolabeled cMORF.
European journal of nuclear medicine and molecular imaging 2008;35(2):272-80.
2007: Xinrong Liu; Yi Wang; Kayoko Nakamura; Guozheng Liu; Shuping Dou; Atsushi Kubo; Mary Rusckowski; Donald J Hnatowich
Optical antisense imaging of tumor with fluorescent DNA duplexes.
Bioconjugate chemistry 2007;18(6):1905-11.
2007: Mary Rusckowski; Suresh Gupta; Guozheng Liu; Shuping Dou; Donald J Hnatowich
Evidence of specificity of radiolabeled phage display peptides for the TAG-72 antigen.
Cancer biotherapy & radiopharmaceuticals 2007;22(4):564-72.
2007: Surong Zhang; Guozheng Liu; Xinrong Liu; Dongguang Yin; Shuping Dou; Jiang He; Mary Rusckowski; Donald J Hnatowich
Comparison of several linear fluorophore- and quencher-conjugated oligomer duplexes for stability, fluorescence quenching, and kinetics in vitro and in vivo in mice.
Bioconjugate chemistry 2007;18(4):1170-5.
2007: Jiang He; Guozheng Liu; Shuping Dou; Suresh Gupta; Mary Rusckowski; Donald J Hnatowich
An improved method for covalently conjugating morpholino oligomers to antitumor antibodies.
Bioconjugate chemistry 2007;18(3):983-8.
2007: Guozheng Liu; Shuping Dou; Dongguang Yin; Shayne Squires; Xinrong Liu; Yi Wang; Mary Rusckowski; Donald J Hnatowich
A novel pretargeting method for measuring antibody internalization in tumor cells.
Cancer biotherapy & radiopharmaceuticals 2007;22(1):33-9.
2007: Guozheng Liu; Shuping Dou; Jiang He; Xinrong Liu; Mary Rusckowski; Donald J Hnatowich
Predicting the biodistribution of radiolabeled cMORF effector in MORF-pretargeted mice.
European journal of nuclear medicine and molecular imaging 2007;34(2):237-46.
2007: Yi Wang; Xinrong Liu; Yumin Zhang; Guozheng Liu; Mary Rusckowski; Donald J Hnatowich
Nonspecific cellular accumulation of 99mTc-labeled oligonucleotides in culture is influenced by their guanine content.
Nuclear medicine and biology 2007;34(1):47-54.
2007: Jiang He; Mary Rusckowski; Yi Wang; Shuping Dou; Xinrong Liu; Surong Zhang; Guozheng Liu; Donald J Hnatowich
Optical pretargeting of tumor with fluorescent MORF oligomers.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2007;9(1):17-23.
2006: Xinrong Liu; Kayoko Nakamura; Yi Wang; Surong Zhang; Jiang He; Guozheng Liu; Shuping Dou; Atsushi Kubo; Mary Rusckowski; Donald J Hnatowich
Improved delivery in cell culture of radiolabeled antisense DNAs by duplex formation.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2006;8(5):278-83.
2006: Guozheng Liu; Shuping Dou; Jiang He; Dongguang Yin; Suresh Gupta; Surong Zhang; Yi Wang; Mary Rusckowski; Donald J Hnatowich
Radiolabeling of MAG3-morpholino oligomers with 188Re at high labeling efficiency and specific radioactivity for tumor pretargeting.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2006;64(9):971-8.
2006: Guozheng Liu; Shuping Dou; George Mardirossian; Jiang He; Surong Zhang; Xinrong Liu; Mary Rusckowski; Donald J Hnatowich
Successful radiotherapy of tumor in pretargeted mice by 188Re-radiolabeled phosphorodiamidate morpholino oligomer, a synthetic DNA analogue.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(16):4958-64.
2006: Yu-Min Zhang; Ching-Hsuan Tung; Jiang He; Ning Liu; Ivan Yanachkov; Guozheng Liu; Mary Rusckowski; Jean-Luc Vanderheyden
Construction of a novel chimera consisting of a chelator-containing Tat peptide conjugated to a morpholino antisense oligomer for technetium-99m labeling and accelerating cellular kinetics.
Nuclear medicine and biology 2006;33(2):263-9.
2006: Xinrong Liu; Kayoko Nakamura; Yi Wang; Yee Wang; Guozheng Liu; Jiang He; Hongliu Ding; Peiyuan Lu; Mary Rusckowski; Atsushi Kubo; Donald J Hnatowich
Initial mechanistic studies of antisense targeting in cells.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(2):360-8.
2005: Guozheng Liu; Jiang He; Shuping Dou; Suresh Gupta; Mary Rusckowski; Donald J Hnatowich
Further investigations of morpholino pretargeting in mice--establishing quantitative relations in tumor.
European journal of nuclear medicine and molecular imaging 2005;32(9):1115-23.
2004: Yumin Zhang; Jiang He; Guozheng Liu; Jean-Luc Venderheyden; Suresh Gupta; Mary Rusckowski; Donald J Hnatowich
Initial observations of 99mTc labelled locked nucleic acids for antisense targeting.
Nuclear medicine communications 2004;25(11):1113-8.
2004: Kayoko Nakamura; C Fan; G Liu; S Gupta; J He; S Dou; Atsushi Kubo; Mary Rusckowski; Donald J Hnatowich
Evidence of antisense tumor targeting in mice.
Bioconjugate chemistry 2004;15(6):1475-80.
2004: Guozheng Liu; Shuping Dou; Jiang He; Jean-Luc Vanderheyden; Mary Rusckowski; Donald J Hnatowich
Preparation and properties of 99mTc(CO)3+-labeled N,N-bis(2-pyridylmethyl)-4-aminobutyric acid.
Bioconjugate chemistry 2004;15(6):1441-6.
2004: Mary Rusckowski; Suresh Gupta; Guozheng Liu; Shuping Dou; Donald J Hnatowich
Investigations of a (99m)Tc-labeled bacteriophage as a potential infection-specific imaging agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(7):1201-8.
2004: Jiang He; Changbin Liu; Jean-Luc Vanderheyden; Guozheng Liu; Shuping Dou; Mary Rusckowski; Donald J Hnatowich
Radiolabelling morpholinos with 188Re tricarbonyl provides improved in vitro and in vivo stability to re-oxidation.
Nuclear medicine communications 2004;25(7):731-6.
2004: Jiang He; Guozheng Liu; Suresh Gupta; Yumin Zhang; Mary Rusckowski; Donald J Hnatowich
Amplification targeting: a modified pretargeting approach with potential for signal amplification-proof of a concept.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(6):1087-95.
2004: Guozheng Liu; Jiang He; Shuping Dou; Suresh Gupta; Jean-Luc Vanderheyden; Mary Rusckowski; Donald J Hnatowich
Pretargeting in tumored mice with radiolabeled morpholino oligomer showing low kidney uptake.
European journal of nuclear medicine and molecular imaging 2004;31(3):417-24.
2003: Jiang He; Guozheng Liu; Surong Zhang; Mary Rusckowski; Donald J Hnatowich
Pharmacokinetics in mice of four oligomer-conjugated polymers for amplification targeting.
Cancer biotherapy & radiopharmaceuticals 2003;18(6):941-7.
2003: Jiang He; Guozheng Liu; Surong Zhang; Jean-Luc Vanderheyden; Ning Liu; Changbin Liu; Yumin Zhang; Suresh Gupta; Mary Rusckowski; Donald J Hnatowich
A comparison of in vitro and in vivo stability in mice of two morpholino duplexes differing in chain length.
Bioconjugate chemistry 2003;14(5):1018-23.
2003: Guillermina Ferro-Flores; Consuelo Arteaga de Murphy; Martha Pedraza-López; Laura Meléndez-Alafort; Yu-Min Zhang; Mary Rusckowski; Donald J Hnatowich
In vitro and in vivo assessment of 99mTc-UBI specificity for bacteria.
Nuclear medicine and biology 2003;30(6):597-603.
2003: Yu-Min Zhang; Chang-Bin Liu; Ning Liu; Guillermina Ferro-Flores; Jiang He; Mary Rusckowski; Donald J Hnatowich
Electrostatic binding with tat and other cationic peptides increases cell accumulation of 99mTc-antisense DNAs without entrapment.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2003;5(4):240-7.
2003: Guozheng Liu; Changbin Liu; Surong Zhang; Jiang He; Ning Liu; Suresh Gupta; Mary Rusckowski; Donald J Hnatowich
Investigations of 99mTc morpholino pretargeting in mice.
Nuclear medicine communications 2003;24(6):697-705.
2003: Chang-bin Liu; Guo-zheng Liu; Ning Liu; Yu-min Zhang; Jiang He; Mary Rusckowski; Donald J Hnatowich
Radiolabeling morpholinos with 90Y, 111In, 188Re and 99mTc.
Nuclear medicine and biology 2003;30(2):207-14.
2003: Zi-Fen Su; Jiang He; Mary Rusckowski; Donald J Hnatowich
In vitro cell studies of technetium-99m labeled RGD-HYNIC peptide, a comparison of tricine and EDDA as co-ligands.
Nuclear medicine and biology 2003;30(2):141-9.
2002: Guozheng Liu; Jiang He; Surong Zhang; Changbin Liu; Mary Rusckowski; Donald J Hnatowich
Cytosine residues influence kidney accumulations of 99mTc-labeled morpholino oligomers.
Antisense & nucleic acid drug development 2002;12(6):393-8.
2002: Guozheng Liu; Surong Zhang; Jiang He; Ning Liu; Suresh Gupta; Mary Rusckowski; Donald J Hnatowich
The influence of chain length and base sequence on the pharmacokinetic behavior of 99mTc-morpholinos in mice.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 2002;46(3):233-43.
2002: Guozheng Liu; Surong Zhang; Jiang He; Zhihong Zhu; Mary Rusckowski; Donald J Hnatowich
Improving the labeling of S-acetyl NHS-MAG(3)-conjugated morpholino oligomers.
Bioconjugate chemistry 2002;13(4):893-7.
2002: Zi-Fen Su; Guozheng Liu; Suresh Gupta; Zhihong Zhu; Mary Rusckowski; Donald J Hnatowich
In vitro and in vivo evaluation of a Technetium-99m-labeled cyclic RGD peptide as a specific marker of alpha(V)beta(3) integrin for tumor imaging.
Bioconjugate chemistry 2002;13(3):561-70.
2002: Guozheng Liu; Kennedy Mang'era; Ning Liu; Suresh Gupta; Mary Rusckowski; Donald J Hnatowich
Tumor pretargeting in mice using (99m)Tc-labeled morpholino, a DNA analog.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(3):384-91.
2002: Guozheng Liu; Charles Wescott; Aaron Sato; Yi Wang; Ning Liu; Yu-Min Zhang; Mary Rusckowski; Donald J Hnatowich
Nitriles form mixed-coligand complexes with (99m)Tc-HYNIC-peptide.
Nuclear medicine and biology 2002;29(1):107-13.
2001: Mary Rusckowski; T Qu; Suresh Gupta; Art Ley; Donald J Hnatowich
A comparison in monkeys of (99m)Tc labeled to a peptide by 4 methods.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(12):1870-7.
2001: Kennedy Mang'era; Guozheng Liu; W Yi; Yumin Zhang; Ning Liu; Suresh Gupta; Mary Rusckowski; Donald J Hnatowich
Initial investigations of 99mTc-labeled morpholinos for radiopharmaceutical applications.
European journal of nuclear medicine 2001;28(11):1682-9.
2001: Yu-Min Zhang; Yi Wang; Ning Liu; Z H Zhu; Mary Rusckowski; Donald J Hnatowich
In vitro investigations of tumor targeting with (99m)Tc-labeled antisense DNA.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(11):1660-9.
2001: Yu-Min Zhang; Mary Rusckowski; Ning Liu; Changbin Liu; Donald J Hnatowich
Cationic liposomes enhance cellular/nuclear localization of 99mTc-antisense oligonucleotides in target tumor cells.
Cancer biotherapy & radiopharmaceuticals 2001;16(5):411-9.
2001: Yi Wang; F Chang; Yumin Zhang; Ning Liu; Guozheng Liu; Suresh Gupta; Mary Rusckowski; Donald J Hnatowich
Pretargeting with amplification using polymeric peptide nucleic acid.
Bioconjugate chemistry 2001;12(5):807-16.
2001: Zhihong Zhu; Yi Wang; Yumin Zhang; Guozheng Liu; Ning Liu; Mary Rusckowski; Donald J Hnatowich
A novel and simplified route to the synthesis of N3S chelators for 99mTc labeling.
Nuclear medicine and biology 2001;28(6):703-8.
2001: T Qu; Yi Wang; Zhihong Zhu; Mary Rusckowski; Donald J Hnatowich
Different chelators and different peptides together influence the in vitro and mouse in vivo properties of 99Tcm.
Nuclear medicine communications 2001;22(2):203-15.
2000: Yu-Min Zhang; Ning Liu; Z H Zhu; Mary Rusckowski; Donald J Hnatowich
Influence of different chelators (HYNIC, MAG3 and DTPA) on tumor cell accumulation and mouse biodistribution of technetium-99m labeled to antisense DNA.
European journal of nuclear medicine 2000;27(11):1700-7.
2000: Mary Rusckowski; T Qu; A Roskey; S Agrawal
Biodistribution and metabolism of a mixed backbone oligonucleotide (GEM 231) following single and multiple dose administration in mice.
Antisense & nucleic acid drug development 2000;10(5):333-45.
2000: Mary Rusckowski; T Qu; James M. Pullman; R Marcel; Art Ley; Robert C Ladner; Donald J Hnatowich
Inflammation and infection imaging with a 99mTc-neutrophil elastase inhibitor in monkeys.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(2):363-74.
1999: Donald J Hnatowich; F Chang; T Qu; Mary Rusckowski
Technetium-99m labeled peptides--an investigation of multiple HPLC peaks.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 1999;50(5):911-21.
1999: F Chang; T Qu; Mary Rusckowski; Donald J Hnatowich
NHS-MAS3: a bifunctional chelator alternative to NHS-MAG3.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 1999;50(4):723-32.
1999: M Fogarasi; James M. Pullman; Paul T Winnard; Donald J Hnatowich; Mary Rusckowski
Pretargeting of bacterial endocarditis in rats with streptavidin and 111In-labeled biotin.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(3):484-90.
1998: Donald J Hnatowich; T Qu; F Chang; Art Ley; Robert C Ladner; Mary Rusckowski
Labeling peptides with technetium-99m using a bifunctional chelator of a N-hydroxysuccinimide ester of mercaptoacetyltriglycine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(1):56-64.
1997: Mary Rusckowski; T Qu; F Chang; Donald J Hnatowich
Pretargeting using peptide nucleic acid.
Cancer 1997;80(12 Suppl):2699-705.
1997: F Chang; Mary Rusckowski; T Qu; Donald J Hnatowich
Early results in the irrational design of new bifunctional chelators.
Cancer 1997;80(12 Suppl):2347-53.
1997: Mary Rusckowski; T Qu; F Chang; Donald J Hnatowich
Technetium-99m labeled epidermal growth factor-tumor imaging in mice.
The journal of peptide research : official journal of the American Peptide Society 1997;50(5):393-401.
1997: Paul T Winnard; F Chang; Mary Rusckowski; George Mardirossian; Donald J Hnatowich
Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA.
Nuclear medicine and biology 1997;24(5):425-32.
1997: George Mardirossian; K Lei; Mary Rusckowski; F Chang; T Qu; M Egholm; Donald J Hnatowich
In vivo hybridization of technetium-99m-labeled peptide nucleic acid (PNA).
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(6):907-13.
1997: Donald J Hnatowich; F Chang; K Lei; T Qu; Mary Rusckowski
The influence of temperature and alkaline pH on the labeling of free and conjugated MAG3 with technetium-99m.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 1997;48(5):587-94.
1997: Mary Rusckowski; M Fogarasi; B Fritz; Donald J Hnatowich
Effect of endogenous biotin on the applications of streptavidin and biotin in mice.
Nuclear medicine and biology 1997;24(3):263-8.
1996: K Lei; Mary Rusckowski; F Chang; T Qu; George Mardirossian; Donald J Hnatowich
Technetium-99m antibodies labeled with MAG3 and SHNH: an in vitro and animal in vivo comparison.
Nuclear medicine and biology 1996;23(7):917-22.
1996: Mary Rusckowski; Giovanni Paganelli; Donald J Hnatowich; P Magnani; F Virzi; M Fogarasi; C DiLeo; F Sudati; Ferruccio Fazio
Imaging osteomyelitis with streptavidin and indium-111-labeled biotin.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(10):1655-62.
1996: Paul T Winnard; E Virzi; M Fogarasi; Mary Rusckowski; Donald J Hnatowich
Investigations of directly labeling antibodies with rhenium-188.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1996;40(2):151-60.
1996: Donald J Hnatowich; George Mardirossian; Mary Rusckowski; Paul T Winnard
Protein labelling via deoxyribonucleic acid hybridization.
Nuclear medicine communications 1996;17(1):66-75.
1996: Donald J Hnatowich; George Mardirossian; M Fogarasi; T Sano; C L Smith; C R Cantor; Mary Rusckowski; Paul T Winnard
Comparative properties of a technetium-99m-labeled single-stranded natural DNA and a phosphorothioate derivative in vitro and in mice.
The Journal of pharmacology and experimental therapeutics 1996;276(1):326-34.
1995: Donald J Hnatowich; Paul T Winnard; F Virzi; M Fogarasi; T Sano; C L Smith; C R Cantor; Mary Rusckowski
Technetium-99m labeling of DNA oligonucleotides.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(12):2306-14.
1995: F Virzi; Paul T Winnard; M Fogarasi; T Sano; C L Smith; C R Cantor; Mary Rusckowski; Donald J Hnatowich
Recombinant metallothionein-conjugated streptavidin labeled with 188Re and 99mTc.
Bioconjugate chemistry 1995;6(1):139-44.
1995: Mary Rusckowski; M Fogarasi; F Virzi; Donald J Hnatowich
Influence of endogenous biotin on the biodistribution of labelled biotin derivatives in mice.
Nuclear medicine communications 1995;16(1):38-46.
1994: Donald J Hnatowich; F Virzi; M Fogarasi; Mary Rusckowski; Paul T Winnard
Can a cysteine challenge assay predict the in vivo behavior of 99mTc-labeled antibodies?
Nuclear medicine and biology 1994;21(8):1035-44.
1994: Donald J Hnatowich; F Virzi; Paul T Winnard; M Fogarasi; Mary Rusckowski
Investigations of ascorbate for direct labeling of antibodies with technetium-99m.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(1):127-34.
1993: Donald J Hnatowich; B Fritz; F Virzi; George Mardirossian; Mary Rusckowski
Improved tumor localization with (strept)avidin and labeled biotin as a substitute for antibody.
Nuclear medicine and biology 1993;20(2):189-95.
1993: Donald J Hnatowich; George Mardirossian; Mary Rusckowski; S Roy; H Bushe; T W Griffin; A Bertrand Brill
Pharmacokinetics of the FO23C5 anti-CEA antibody fragment labelled with 99Tcm and 111In: a comparison in patients.
Nuclear medicine communications 1993;14(1):52-63.
1993: Donald J Hnatowich; George Mardirossian; Mary Rusckowski; M Fogarasi; F Virzi; Paul T Winnard
Directly and indirectly technetium-99m-labeled antibodies--a comparison of in vitro and animal in vivo properties.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(1):109-19.
1992: Mary Rusckowski; B Fritz; Donald J Hnatowich
Localization of infection using streptavidin and biotin: an alternative to nonspecific polyclonal immunoglobulin.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(10):1810-5.
1992: George Mardirossian; C Wu; Mary Rusckowski; Donald J Hnatowich
The stability of 99Tcm directly labelled to an Fab' antibody via stannous ion and mercaptoethanol reduction.
Nuclear medicine communications 1992;13(7):503-12.
1992: Donald J Hnatowich; Mary Rusckowski; D A Siebecker; M Gionet; George Mardirossian; H S Bushe; S Roy; J A Mattis; D Shealy; T W Griffin
Pharmacokinetics of indium-111 labeled 10-3D2 antibreast-tumor antibody in patients.
Journal of nuclear biology and medicine (Turin, Italy : 1991) 1992;36(1):7-13.
1991: T W Griffin; A Bertrand Brill; S Stevens; J A Collins; F Bokhari; H Bushe; M C Stochl; M Gionet; Mary Rusckowski; S D Stroupe
Initial clinical study of indium-111-labeled clone 110 anticarcinoembryonic antigen antibody in patients with colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(4):631-40.
1991: F Virzi; B Fritz; Mary Rusckowski; M Gionet; H Misra; Donald J Hnatowich
New indium-111 labeled biotin derivatives for improved immunotargeting.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(7):719-26.
1990: Donald J Hnatowich; Mary Rusckowski; A Bertrand Brill; D A Siebecker; H Misra; George Mardirossian; H Bushe; A Rescigno; S Stevens; D K Johnson
Pharmacokinetics in patients of an anti-carcinoembryonic antigen antibody radiolabeled with indium-111 using a novel diethylenetriamine pentaacetic acid chelator.
Cancer research 1990;50(22):7272-8.
1990: Haralabos P Kalofonos; Mary Rusckowski; D A Siebecker; G B Sivolapenko; D Snook; J P Lavender; Agamemnon A Epenetos; Donald J Hnatowich
Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(11):1791-6.
1990: A Rescigno; H Bushe; A Bertrand Brill; Mary Rusckowski; T W Griffin; Donald J Hnatowich
Pharmacokinetic modeling of radiolabeled antibody distribution in man.
American journal of physiologic imaging 1990;5(4):141-50.
1987: Donald J Hnatowich; M Gionet; Mary Rusckowski; D A Siebecker; J Roche; D Shealy; J A Mattis; J Wilson; J McGann; R E Hunter
Pharmacokinetics of 111In-labeled OC-125 antibody in cancer patients compared with the 19-9 antibody.
Cancer research 1987;47(22):6111-7.
1987: Donald J Hnatowich; F Virzi; Mary Rusckowski
Investigations of avidin and biotin for imaging applications.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1987;28(8):1294-302.
1985: Donald J Hnatowich; T W Griffin; C Kosciuczyk; Mary Rusckowski; R L Childs; J A Mattis; D Shealy; P W Doherty
Pharmacokinetics of an indium-111-labeled monoclonal antibody in cancer patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1985;26(8):849-58.
1985: Mary Rusckowski; P W Doherty; F Virzi; Donald J Hnatowich
A simple in vitro method of screening panels of monoclonal antibodies for tumor binding.
Journal of immunological methods 1985;76(2):375-82.